The Support, Educate, Empower (SEE) Personalized Glaucoma Coaching Trial Results
Recommended Citation
Newman-Casey PA, Niziol L, Lu M, Darnley-Fisch D, Resnicow K, Mitchell J, Imami NR, Heisler M. The Support, Educate, Empower (SEE) Personalized Glaucoma Coaching Trial Results. Invest Ophthalmol Vis Sci 2025; 66(8).
Document Type
Conference Proceeding
Publication Date
6-1-2025
Publication Title
Invest Ophthalmol Vis Sci
Abstract
Purpose : Test the effect of the Support, Educate, Empower (SEE) personalized glaucomacoaching program in a sample of medically-treated glaucoma participants with poor self-reported adherence on the following outcomes: 1) the primary outcome, medicationadherence; 2) the secondary outcome, glaucoma-related distress (GRD); 3) the exploratoryoutcome, intraocular pressure (IOP).Methods : Patients with glaucoma taking ≥1 eyedrop medications and self-reportingadherence ≤85% were recruited from two sites (University of Michigan [UM] and HenryFord Health System [HFHS]). Eligible participants were randomized 1:1 to the SEEintervention or usual care. The SEE intervention included motivational interviewing-basedcoaching alongside personalized glaucoma education at three in-person sessions from atrained non-physician counselor, four between-visit phone calls to discuss adherencescore, and automated medication reminders. All participants were followed for 6 monthsduring which medication adherence was monitored electronically (AdhereTech, New York,NY), and GRD (Modified Diabetes Distress Scale) and IOP (iCare tonometer; Tiolat Oy,Helsinki, Finland) were measured at study enrollment and exit. Medication adherence wascalculated as the percentage of doses taken by doses prescribed over the 6-month studyperiod. Outcomes were compared between SEE intervention and usual care groups with 2-sample t- and Wilcoxon tests.Results : 235 participants were enrolled (107 UM, 128 HFHS) and randomized (117 SEEintervention, 118 control). Participants were 67±11 (mean±standard deviation) years old,53% female, 30% White and 61% Black, and 63% reported income <$60k, 24% $61-$120k,and 13% >$120k. Electronically monitored adherence was significantly better in SEEintervention participants than usual care (77.6%±19.7 vs 58.0%±25.2, respectively,p<0.0001), as was change in GRD (-0.58±0.87 vs -0.23±0.74, p=0.003), and IOP in the eyewith worse mean deviation trended towards improvement (-1.01±4.54 vs 0.15±3.72,p=0.12) while IOP in the eye with better mean deviation showed no difference (-0.36±3.43vs -0.14±4.91, p=0.49).Conclusions : The SEE personalized glaucoma coaching program was a multi-facetedintervention that improved medication adherence and glaucoma related distress inglaucoma patients with poor self-reported adherence. There was a trend towards animprovement in IOP control.
Volume
66
Issue
8
